SynDRA canonical compound SYN0006067 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | TOP2A |
| Mechanism of action | Topoisomerase inhibitor |
| Indication | acute lymphoblastic leukemia (ALL) | acute myeloid leukemia (AML) |
| Disease area | hematologic malignancy |